Effects of intrahippocampal aniracetam treatment on Y-maze avoidance learning performance and behavioral long-term potentiation in dentate gyrus in rat

Neurosci Lett. 2001 Feb 9;298(3):183-6. doi: 10.1016/s0304-3940(00)01744-4.

Abstract

Effects of intrahippocampal treatment of aniracetam, a selective agonist for DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproionic acid (AMPA) receptors, on Y-maze avoidance learning task and behavioral long-term potentiation (LTP) in perforant path-dentate gyrus were studied in freely moving rats by using in vivo electrophysiology combined with behavioral tests. The results were as follows: (1) intrahippocampal treatment of aniracetam reversibly enhanced basal synaptic transmission in perforant path to dentate gyrus in a dosage dependent manner; (2) aniracetam produced improvement in Y-maze learning performance when administration occurred 5 min prior to maze learning; (3) aniracetam administration significantly facilitated behavioral LTP in dentate gyrus, while the maximal amplitude of LTP has no significant difference when compared to saline group. The present results indicate that hippocampal AMPA receptors are involved in learning and memory.

MeSH terms

  • Animals
  • Avoidance Learning / drug effects
  • Avoidance Learning / physiology
  • Behavior, Animal / drug effects
  • Behavior, Animal / physiology
  • Dentate Gyrus / drug effects*
  • Dentate Gyrus / physiology
  • Electrophysiology
  • Electroshock
  • Long-Term Potentiation / drug effects*
  • Long-Term Potentiation / physiology
  • Male
  • Maze Learning / drug effects*
  • Maze Learning / physiology
  • Memory / drug effects
  • Memory / physiology
  • Microinjections
  • Nootropic Agents / pharmacology*
  • Pyrrolidinones / pharmacology*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Nootropic Agents
  • Pyrrolidinones
  • aniracetam